Clinical Trial: A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332117) titled 'A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications' on Sept. 23, 2025.

Brief Summary: To assess the impact on body mass composition from anti-fibrotic medications used in fibrotic lung disease by using BIA and muscle ultrasound

Study Start Date: Sept. 09, 2025

Study Type: OBSERVATIONAL

Condition: Idiopathic Pulmonary Fibrosis (IPF) Progressive Pulmonary Fibrosis

Intervention: OTHER: No Interventions

No intervention

OTHER: No intervention

No intervention

Recruitment Status: RECRUITING

Sponsor: Royal Brompton & Harefield NHS Foundati...